ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Austin, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Adenocarcinoma
Recurrence
Castration-Resistant Prostatic Cancer

Prostate Cancer trials near Austin, TX, USA:

A Clinical Study of ONCT-534 in Subjects With Metastatic Castration-resistant Prostate Cancer.

A first-in-human clinical trial to test the investigational treatment ONCT-534 in participants with metastatic castration-resistant prostate ...

Enrolling
Metastatic Castration-resistant Prostate Cancer
Drug: ONCT-534

Phase 1, Phase 2

Oncternal Therapeutics

Austin, Texas, United States and 8 other locations

The goal of this clinical trial is to assess the performance and safety of the AQUABEAM Robotic System for the resection and removal of prostate...

Enrolling
Benign Prostatic Hyperplasia
Localized Prostate Cancer
Device: Robotic Waterjet Treatment
PROCEPT BioRobotics

Austin, Texas, United States and 3 other locations

Recently updated

radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak kills tumor cells and stimulates a ...

Active, not recruiting
Prostate Cancer
Biological: Placebo + valacyclovir
Biological: Aglatimagene besadenovec + valacyclovir

Phase 3

Candel Therapeutics

Austin, Texas, United States and 72 other locations

of the Vanquish Water Vapor Ablation Device ("Vanquish") in treating subjects with Gleason Grade Group 2 (GGG2) localized intermediate-risk prostate...

Enrolling
Prostate Cancer
Device: Vanquish System
Francis Medical

Austin, Texas, United States and 29 other locations

plus docetaxel in participants with metastatic castration resistant prostate cancer (mCRPC), all participants will receive the doce...

Enrolling
Prostate Cancer
Drug: docetaxel
Drug: capivasertib

Phase 3

AstraZeneca
AstraZeneca

Austin, Texas, United States and 249 other locations

A Phase 1 Dose Escalation and Expanded Cohort Study Of PF-06821497 In The Treatment Of Adult Patients With Relapsed/Refractory Small Cell Lung Cancer...

Enrolling
Castration Resistant Prostate Cancer (CRPC)
Small Cell Lung Cancer (SCLC)
Drug: PF-06821497

Phase 1

Pfizer
Pfizer

Austin, Texas, United States and 100 other locations

is to evaluate the effectiveness, safety and tolerability of nivolumab followed by ipilimumab, in subjects with metastatic castration resistant prostate...

Active, not recruiting
Prostate Cancer
Biological: Nivolumab
Biological: Ipilimumab

Phase 2

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Austin, Texas, United States and 58 other locations

Researchers are looking for a better way to treat men at high-risk of biochemical recurrence (BCR) of prostate cancer.BCR means tha ...

Enrolling
Biochemically Recurrent Prostate Cancer
Other: Placebo matching darolutamide
Drug: Darolutamide (BAY1841788, Nubeqa)

Phase 3

Bayer
Bayer

Austin, Texas, United States and 263 other locations

The purpose of this study is to learn whether adding abemaciclib to abiraterone plus prednisone prolongs the time before prostate cancer...

Active, not recruiting
Prostatic Neoplasms
Cytochrome P-450
Drug: Placebo for Abemaciclib
Drug: Abemaciclib

Phase 3

Lilly
Lilly

Austin, Texas, United States and 269 other locations

Locations recently updated

Repair (HRR) gene-mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC) provides superior efficacy in improving radiograp...

Active, not recruiting
Metastatic Castration-sensitive Prostate Cancer
Drug: Niraparib
Drug: Prednisone

Phase 3

Janssen (J&J Innovative Medicine)
Janssen (J&J Innovative Medicine)

Austin, Texas, United States and 386 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems